In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Marco Guazzi
Marco Guazzi Marco Guazzi

IRCCS Polyclinic San Donato, Milan (Italy)

Specialities : Chronic Heart Failure , Echocardiography, Hypertension, Pulmonary Circulation-Pulmonary Embolism-Right Heart Failure, Rehabilitation and Sports Cardiology

Marco Guazzi is a Full Professor of Cardiology at the University of Milano and Head of Heart Failure Unit in the Cardiology Division at I.R.C.C.S. San Donato University Hospital, Milano, Italy. His research focuses on the strategies by which heart failure therapies should be tailored to hemodynamic profiles and cardiopulmonary responses during exercise and the pathogenetic mechanisms and clinical correlates of pulmonary hypertension in heart failure patients. He has established several clinical research programmes into heart failure evaluation and therapy and pulmonary vascular disease. Between 2017 and 2019 he serves as Treasurer of the EACP Board of the ESC. He has been co-author of several Consensus Documents and Guidelines by the European Society of Cardiology and American Heart Association. Prof. Guazzi is a Fellow of the European Society of Cardiology, the American College of Cardiology, the American Heart Association. Prof. Guazzi serves the Editorial Board of the European Jo

20 presentations from this speaker

Cardiac remodelling in patients treated with sacubitril/valsartan – what have studies shown?

Event : HFA Discoveries 2020

  • Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
  • Speaker : M Guazzi (San Donato Milanese,IT)
  • Sponsorered by Novartis Pharma AG

Experts on the Spot: Cardiac remodelling and outcomes.

Event : HFA Discoveries 2020

  • Session : Experts on the Spot: Cardiac remodelling and outcomes
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)
  • Sponsored by Novartis Pharma AG

Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?

Event : HFA Discoveries 2020

  • Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)
  • Sponsorered by Novartis Pharma AG

EAPC Finances: report from the Treasurer

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : EAPC General Assembly
  • Speaker : M Guazzi (San Donato Milanese,IT)

Recommendations for exercise prescription in hypertension: an update.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Exercise and blood pressure in cardiovascular prevention: what can be achieved?
  • Speaker : M Guazzi (San Donato Milanese,IT)

Symptomatic non severe heart valve disease.

Event : EuroEcho 2018

  • Session : Exercise echo in valvular heart disease
  • Speaker : M Guazzi (San Donato Milanese,IT)

The added value of CPET to exercise-echocardiography: clinical application and methodological issues.

Event : EuroEcho 2018

  • Session : Live session - Adding functional evaluation to stress echocardiography: the role of cardiopulmonary exercise test
  • Speaker : M Guazzi (San Donato Milanese,IT)

The failing right heart in left heart diseases.

Event : ESC Congress 2018

  • Session : Pulmonary hypertension due to left heart disease: look RIGHT !
  • Speaker : M Guazzi (San Donato Milanese,IT)

Importance of the RV for the management.

Event : EuroEcho 2017

  • Session : Heart failure and ischemia
  • Speaker : M Guazzi (San Donato Milanese,IT)

Any role of ventilation?

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2016

  • Session : Exercise performance in heart failure with preserved ejection fraction
  • Speaker : M Guazzi (San Donato Milanese,IT)

More exercise: better or worse? Conclusion

Event : ESC Congress 2016

  • Session : More exercise: better or worse?
  • Speaker : M Guazzi (San Donato Milanese,IT)

Right ventricular dysfunction in heart failure with either reduced or preserved LV function

Event : Heart Failure 2016

  • Session : Chronic heart failure
  • Speaker : M Guazzi (San Donato Milanese,IT)

Case reports II: Prognostic and Diagnostic Stratification for CHF patients.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Performing and interpreting a cardiopulmonary exercise test – from athletes to heart failure patients - III
  • Speaker : M Guazzi (San Donato Milanese,IT)

Evaluation in patients with HFpEF or HFrEF.

Event : Heart Failure 2015

  • Session : Pulmonary hypertension: look left, look right !
  • Speaker : M Guazzi (San Donato Milanese,IT)

Exercise gas exchange phenotypes in a population at risk according to levels of oxygen consumption at peak exercise: findings from the EURO(pean) EX(ercise) population-based study

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Prevention, Epidemiology & Population Science
  • Speaker : M Guazzi (San Donato Milanese,IT)

First evidence for occurrence of exercise oscillatory ventilation in a general population at cardiovascular risk: insights from the EURO(pean) EX(ercise) population-based study

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Prevention, Epidemiology & Population Science
  • Speaker : M Guazzi (San Donato Milanese,IT)

Scientific highlights in exercise, basic and translational research

Event : ESC Congress 2015

  • Session : The year in prevention: scientific highlights from EuroPRevent 2015 and beyond
  • Speaker : M Guazzi (San Donato Milanese,IT)

Assesment for exercise prescription in heart failure.

Event : ESC Congress 2014

  • Session : Exercise training in heart failure
  • Speaker : M Guazzi (San Donato Milanese,IT)

Phosphodiesterase-5 inhibitors.

Event : ESC Congress 2014

  • Session : Chronic heart failure treatment: what lies ahead
  • Speaker : M Guazzi (San Donato Milanese,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are